No significant associations were observed between ezrin and moesin expression in the stromal compartments and tumour blood vessels and clinicopathological parameters, although a weak correlation between enhanced immunoreactivity of ezrin in the stroma and the postmenopausal status of patients was noted (P = 0.042) (Table 4). The gene discussed is EZR; the disease is neoplasm.